MedTrace Logo

Singapore Neurologic Infections Program

NCT02017665 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2017-04-27

No results posted yet for this study

Summary

Worldwide, central nervous system infections such as inflammation of brain (encephalitis), inflammation of meninges (meningitis) and sudden onset of weakness of muscles which maybe infectious in origin result in significant illness and death and healthcare costs. Vast majority of central nervous system infections remain without an identifiable cause. There is also concern about new and emerging infections.

This study thus intends to fill in the gaps in knowledge with regards to central nervous system infections in Singapore to give a thorough description of burden of causes of central nervous system infections and detection of outbreaks of new pathogens. Patients suspected of central nervous system infection will be recruited from 5 restructured Singapore hospitals and their blood and other clinical specimens will be sent for testing. Patients will also be followed up to assess long term outcomes and socio-economic costs of these infections. This will help clinicians, policymakers and public health officials in estimating financial and societal costs of CNs infections in Singapore.

Conditions

  • Central Nervous System Infections

Sponsors & Collaborators

  • Tan Tock Seng Hospital

    collaborator OTHER

  • Duke-NUS Graduate Medical School

    collaborator OTHER

  • Changi General Hospital

    collaborator OTHER

  • Khoo Teck Puat Hospital

    collaborator OTHER

  • National University Health System, Singapore

    collaborator OTHER

  • Singapore General Hospital

    lead OTHER

Principal Investigators

  • Limin Wijaya, MD · SGH

Eligibility

Min Age
21 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02017665 on ClinicalTrials.gov